EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.2.1.36 | 10'-apo-beta-carotenal + NAD+ + H2O |
i.e. (2E,4E,6E,8E,10E,12E,14E)-4,9,13-trimethyl-15-(2,6,6-trimethylcyclohex-1-en-1-yl)pentadeca-2,4,6,8,10,12,14-heptaenal |
Homo sapiens |
10'-apo-beta-carotenoic acid + NADH + 2 H+ |
- |
? |
1.2.1.36 | 12'-apo-beta-carotenal + NAD+ + H2O |
i.e. (2E,4E,6E,8E,10E,12E)-2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)trideca-2,4,6,8,10,12-hexaenal |
Homo sapiens |
12'-apo-beta-carotenoic acid + NADH + 2 H+ |
- |
? |
1.2.1.36 | 13-cis-retinal + NAD+ + H2O |
type-2 isozyme |
Mus musculus |
13-cis-retinoate + NADH |
- |
? |
1.2.1.36 | 13-cis-retinal + NAD+ + H2O |
type-2 isozyme, 2fold lower activity compared to all-trans-retinal |
Mus musculus |
13-cis-retinoate + NADH |
- |
? |
1.2.1.36 | 13-cis-retinal + NAD+ + H2O |
- |
Mus musculus |
13-cis-retinoate + NADH + H+ |
- |
? |
1.2.1.36 | 13-cis-retinal + NAD+ + H2O |
isoform RALDH4 oxidizes 13-cis retinal with lower catalytic efficiency than 9-cis retinal |
Mus musculus |
13-cis-retinoate + NADH + H+ |
- |
? |
1.2.1.36 | 14'-apo-beta-carotenal + NAD+ + H2O |
i.e. (2E,4E,6E,8E,10E)-5,9-dimethyl-11-(2,6,6trimethylcyclohex-1-en-1-yl)undeca-2,4,6,8,10-pentaenal |
Homo sapiens |
14'-apo-beta-carotenoic acid + NADH + 2 H+ |
- |
? |
1.2.1.36 | 2,4-decadienal + NAD+ + H2O |
- |
Homo sapiens |
2,4-decadienoate + NADH + H+ |
- |
? |
1.2.1.36 | 2,4-decadienal + NAD+ + H2O |
- |
Rattus norvegicus |
2,4-decadienoate + NADH + H+ |
- |
? |
1.2.1.36 | 2,4-decadienal + NAD+ + H2O |
- |
Rattus norvegicus |
2,4-decadienoate + NADH + 2 H+ |
- |
? |